1. 평균 포도당과 당화혈색소 관계
Table 6.1 shows the correlation between A1C levels and mean glucose levels based on the international A1C-Derived Average Glucose (ADAG) study, which assessed the correlation between A1C and frequent BGM and CGM in 507 adults (83% non-Hispanic White) with type 1, type 2, and no diabetes (13), and an empirical study of the average blood glucose levels at premeal, postmeal, and bedtime associated with specified A1C levels using data from the ADAG trial (14). The American Diabetes Association (ADA) and the American Association for Clinical Chemistry have determined that the correlation (r = 0.92) in the ADAG trial is strong enough to justify reporting both the A1C result and the estimated average glucose (eAG) result when a clinician orders the A1C test. Clinicians should note that the mean plasma glucose numbers in Table 6.1 are based on ∼2,700 readings per A1C measurement in the ADAG trial.
2. CGM과 당화혈색소 관계
Recommendations
- 6.3 Standardized, single-page glucose reports from continuous glucose monitoring (CGM) devices with visual cues, such as the ambulatory glucose profile, should be considered as a standard summary for all CGM devices. E
- 6.4 Time in range is associated with the risk of microvascular complications and can be used for assessment of glycemic control. Additionally, time below range and time above range are useful parameters for the evaluation of the treatment plan (Table 6.2 ). C
3. 성인 비임신 당뇨병에서 권고 혈당과 당화혈색소. ADA 2023
4. 혈당 조절 목표의 개별화. ADA 2023
'내분비내과 > 당뇨병' 카테고리의 다른 글
당뇨병 환자에서 고혈압 목표, ADA 2023 (0) | 2023.02.22 |
---|---|
당뇨병과 심혈관질환 관리 (고혈압, 이상지질혈증), ADA 2023 (0) | 2023.02.12 |
제2형당뇨병과 비만/과체중 - 체중 감량, 도움이 되는 약제들 (0) | 2023.02.12 |
당뇨병에서 권고되는 예방접종. ADA 2023 (0) | 2023.02.12 |
제2형 당뇨병 예방과 지연 (스타틴, 피오글리타존, 고위험군 적극적 감시) ADA 2023 (0) | 2023.02.12 |